HCM
SNTI icon

Heights Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Heights Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-381,384
Closed -$805K – 203
2025
Q2 		$805K Sell
381,384
-368,616
-49% -$1.17M 0.21% 58
2025
Q1 		$2.52M Buy
+750,000
New +$2.92M 1.18% 19

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Heights Capital Management's SNTI Position: Q3 2025 in Review

Heights Capital Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2025, closing a stake of 381,384 shares — an estimated $805K sold.

Heights Capital Management first reported a position in SNTI in Q1 2025 and held it in 2 quarters. The position peaked at $2.52M in Q1 2025. 16 funds tracked by Wall St. Rank hold SNTI as of Q3 2025.

  • Heights Capital Management reported no remaining Senti Biosciences Holdings position as of Q3 2025 after selling out during the quarter.
  • Heights Capital Management sold 381,384 Senti Biosciences Holdings shares in Q3 2025, an estimated $805K.
  • Heights Capital Management first reported a position in Senti Biosciences Holdings in Q1 2025 and held it in 2 quarters.
  • Heights Capital Management's Senti Biosciences Holdings position peaked at $2.52M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2025.

Based on Heights Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.